期刊
FERTILITY AND STERILITY
卷 108, 期 2, 页码 333-340出版社
ELSEVIER SCIENCE INC
DOI: 10.1016/j.fertnstert.2017.06.015
关键词
Hyperandrogenic; PCOS; pregnancy complications
资金
- Euroscreen
- Ferring
- NGI (Netherlands Genomics Initiative)
- Merck Diagnostics
- Merck-Serono
- Merck Sharpe
- Dome
- Molecular Biometrics
- Progyny
- Merck
- Actavis
- COGI
- Finox
- Gedeon-Richter
- Hartstichting
- PregLem
- Ova-Science
- Pantharei Bioscience
- Roche
- Watson Laboratories
- UMC Utrecht Child Health research program
- ZonMW [209020004]
- Dutch Heart Foundation [2013T083]
Objective: To study the presence of several maternal and neonatal complications in a cohort of women with hyperandrogenic as well as normoandrogenic polycystic ovary syndrome (PCOS) and women with PCOS who received different fertility treatments. Design: Prospective multicenter cohort study. Setting: Hospitals and midwifery practices. Patient(s): One hundred and eighty-eight women with PCOS and singleton pregnancies (study group) and 2,889 women with a naturally conceived singleton pregnancy (reference group). Intervention(s): Observational study. Main Outcome Measure(s): Maternal and neonatal pregnancy complications. Result(s): Women with PCOS had a statistically significantly increased risk of developing gestational diabetes (adjusted odds ratio [AOR] 4.15; 95% confidence interval [CI], 2.07-8.33) compared with the reference group, and their infants were more often born small for gestational age (AOR 3.76; 95% CI, 1.69-8.35). In a subgroup analysis, maternal complications were statistically significantly more often present in women with hyperandrogenic (defined as a free androgen index > 4.5) PCOS (n = 76; 40% of all PCOS women) compared with those with normoandrogenic PCOS (n = 97; 52% of all PCOS women) (45% vs. 24%; P=.003); no statistically significant differences were observed between these groups regarding neonatal complications. Conclusion(s): Women with PCOS have an increased risk of maternal and neonatal pregnancy complications, especially women with the hyperandrogenic phenotype. (C) 2017 by American Society for Reproductive Medicine.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据